These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 615726)

  • 1. Effect of portacaval shunt on serum bile acid concentration in patients with cirrhosis.
    Poupon RE; Poupon RY; Grosdemouge ML; Erlinger S
    Digestion; 1977; 16(1-2):138-45. PubMed ID: 615726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in serum bile acid composition between unoperated cirrhotic patients and patients with portacaval or mesocaval shunt.
    Angelico M; Attili AF; Cantafora A; Lombardi M; Thau A; Capocaccia L
    Digestion; 1979; 19(2):126-30. PubMed ID: 478189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of portacaval shunt and arterialization of the liver on bile acid metabolism.
    Horak W; Gangl A; Funovics J; Grabner G
    Gastroenterology; 1975 Aug; 69(2):338-41. PubMed ID: 1150042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy.
    Thompson JS; Porter KA; Hayashida N; McNamara DJ; Parker TS; Russell WJ; Francavilla A; Starzl TE
    Hepatology; 1983; 3(4):581-7. PubMed ID: 6862371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bile acid concentrations in patients with liver disease.
    Fausa O; Gjone E
    Scand J Gastroenterol; 1976; 11(5):537-43. PubMed ID: 959769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum concentration of bile acids and portal hypertension in cirrhotic patients. Possible correlations].
    Tarantino G; Cambri S; Ferrara A; Marzano M; Liberti A; Vellone G; Ciccarelli AF
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):195-205. PubMed ID: 2640042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary beneficial effect of arterialization of the liver in cirrhotic dogs with a portacaval shunt. A preliminary report.
    Terpstra OT; van Vroonhoven TJ; Noordhoek J; ten Kate FJ; Wilson JH
    Eur Surg Res; 1982; 14(5):333-43. PubMed ID: 7128651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfated bile acids in serum, bile, and urine of cirrhotic patients before and after portacaval anastomosis.
    Capocaccia L; Attili AF; Cantafora A; Bracci F; Paciscopi L; Puoti C; Pièche U; Angelico M
    Dig Dis Sci; 1981 Jun; 26(6):513-7. PubMed ID: 7238270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts.
    Senior RM; Britton RC; Turino GM; Wood JA; Langer GA; Fishman AP
    Circulation; 1968 Jan; 37(1):88-96. PubMed ID: 5634734
    [No Abstract]   [Full Text] [Related]  

  • 12. Intestinal phase of gastric acid secretion in humans with and without portacaval shunt.
    Lenz HJ; Hogan DL; Isenberg JI
    Gastroenterology; 1985 Oct; 89(4):791-6. PubMed ID: 3928422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt.
    Poupon RY; Poupon RE; Lebrec D; Le Quernec L; Darnis F
    Gastroenterology; 1981 Jun; 80(6):1438-44. PubMed ID: 7227769
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of serum bile acids in cirrhosis.
    Mannes GA; Thieme C; Stellaard F; Wang T; Sauerbruch T; Paumgartner G
    Hepatology; 1986; 6(1):50-3. PubMed ID: 3943790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid concentrations in systemic and portal serum in presumably normal man and in cholestatic and cirrhotic conditions.
    Lindblad L; Lundholm K; Schersten T
    Scand J Gastroenterol; 1977; 12(4):395-400. PubMed ID: 560715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile flow and biliary sulfobromophthalein sodium excretion in rats with liver cirrhosis and portacaval shunt.
    Zsigmond G; Bodnár A; Schaff Z; Karácsonyi S
    Eur Surg Res; 1982; 14(5):344-57. PubMed ID: 7128652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of 187 troncular portacaval shunts. Statistical analysis of prognosis factors 1. Overall view of the patients and results].
    Leger L; Lenriot JP; Duclos JM; Lemairge G
    J Chir (Paris); 1974; 108(1-2):31-46. PubMed ID: 4548426
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of the secretion of pepsinogen I in cirrhotic humans with and without portacaval shunt.
    Albillos A; Abreu L; Alvarez-Mon M; Gea F; Gonzalo MA; Rossi I; Garrido A; Barrios C; Escartín P
    Am J Gastroenterol; 1988 Jan; 83(1):37-41. PubMed ID: 3337058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.